Depatuxizumab mafodotin is an antibody-drug conjugate (ADC) which specifically targets the epidermal growth factor receptor (EGFR). Depatuxizumab mafodotin can induce cell death in glioma cell lines overexpressing EGFR or EGFRvIII.
Molecular Weight:
148240
Purity:
99.0%
CAS Number:
[1585973-65-4]
* VAT and and shipping costs not included. Errors and price changes excepted